{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T12:48:16Z","timestamp":1792068496556,"version":"4.4.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,10,15]],"date-time":"2022-10-15T00:00:00Z","timestamp":1665792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,10,15]],"date-time":"2022-10-15T00:00:00Z","timestamp":1665792000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl. Stroke Res."],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1007\/s12975-022-01097-2","type":"journal-article","created":{"date-parts":[[2022,10,15]],"date-time":"2022-10-15T14:02:41Z","timestamp":1665842561000},"page":"833-841","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Associations Between Drug Treatments and the Risk of Aneurysmal Subarachnoid Hemorrhage: a Systematic Review and Meta-analysis"],"prefix":"10.1007","volume":"14","author":[{"given":"Kampei","family":"Shimizu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiro","family":"Aoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nima","family":"Etminan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina A. M.","family":"Hackenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoichi","family":"Tani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirotoshi","family":"Imamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroharu","family":"Kataoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuyuki","family":"Sakai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,15]]},"reference":[{"key":"1097_CR1","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1177\/1747493018790033","volume":"13","author":"MDI Vergouwen","year":"2018","unstructured":"Vergouwen MDI, Rinkel GJE, Algra A, Fiehler J, Steinmetz H, Vajkoczy P, et al. Prospective randomized open-label trial to evaluate risk factor management in patients with unruptured intracranial aneurysms: study protocol. Int J Stroke. 2018;13:992\u20138.","journal-title":"Int J Stroke"},{"key":"1097_CR2","doi-asserted-by":"publisher","first-page":"3156","DOI":"10.1161\/STROKEAHA.111.619411","volume":"42","author":"DM Hasan","year":"2011","unstructured":"Hasan DM, Mahaney KB, Brown RD, Meissner I, Piepgras DG, Huston J, et al. Aspirin as a promising agent for decreasing incidence of cerebral aneurysm rupture. Stroke. 2011;42:3156\u201362.","journal-title":"Stroke"},{"key":"1097_CR3","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1161\/STROKEAHA.117.019972","volume":"49","author":"A Can","year":"2018","unstructured":"Can A, Castro VM, Dligach D, Finan S, Yu S, Gainer V, et al. Lipid-lowering agents and high HDL (high-density lipoprotein) are inversely associated with intracranial aneurysm rupture. Stroke. 2018;49:1148\u201354.","journal-title":"Stroke"},{"key":"1097_CR4","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.jstrokecerebrovasdis.2013.04.022","volume":"23","author":"Y Yoshimura","year":"2014","unstructured":"Yoshimura Y, Murakami Y, Saitoh M, Yokoi T, Aoki T, Miura K, et al. Statin use and risk of cerebral aneurysm rupture: a hospital-based case-control study in Japan. J Stroke Cerebrovasc Dis. 2014;23:343\u20138.","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"1097_CR5","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1161\/STROKEAHA.116.015674","volume":"48","author":"K Phan","year":"2017","unstructured":"Phan K, Moore JM, Griessenauer CJ, Ogilvy CS, Thomas AJ. Aspirin and risk of subarachnoid hemorrhage: systematic review and meta-analysis. Stroke. 2017;48:1210\u20137.","journal-title":"Stroke"},{"key":"1097_CR6","doi-asserted-by":"publisher","first-page":"646613","DOI":"10.3389\/fneur.2021.646613","volume":"12","author":"S Yang","year":"2021","unstructured":"Yang S, Liu T, Wu Y, Xu N, Xia L, Yu X. The role of aspirin in the management of intracranial aneurysms: a systematic review and meta-analyses. Front Neurol. 2021;12:646613.","journal-title":"Front Neurol"},{"key":"1097_CR7","doi-asserted-by":"publisher","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","volume":"6","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6:e1000097.","journal-title":"PLoS Med"},{"key":"1097_CR8","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.jclinepi.2012.09.016","volume":"66","author":"SY Kim","year":"2013","unstructured":"Kim SY, Park JE, Lee YJ, Seo H-J, Sheen S-S, Hahn S, et al. Testing a tool for assessing the risk of bias for nonrandomized studies showed moderate reliability and promising validity. J Clin Epidemiol. 2013;66:408\u201314.","journal-title":"J Clin Epidemiol"},{"key":"1097_CR9","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1161\/STROKEAHA.116.015674","volume":"48","author":"K Phan","year":"2017","unstructured":"Phan K, Moore JM, Griessenauer CJ, Ogilvy CS, Thomas AJ. Aspirin and risk of subarachnoid hemorrhage. Stroke. 2017;48:1210\u20137.","journal-title":"Stroke"},{"key":"1097_CR10","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.1161\/01.STR.0000080380.56799.DD","volume":"34","author":"S Juvela","year":"2003","unstructured":"Juvela S. Prehemorrhage risk factors for fatal intracranial aneurysm rupture. Stroke. 2003;34:1852\u20137.","journal-title":"Stroke"},{"key":"1097_CR11","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1111\/j.1538-7836.2010.04170.x","volume":"9","author":"R Risselada","year":"2011","unstructured":"Risselada R, Straatman H, Van Kooten F, Dippel DWJ, Van Der Lugt A, Niessen WJ, et al. Platelet aggregation inhibitors, vitamin K antagonists and risk of subarachnoid hemorrhage. J Thromb Haemost. 2011;9:517\u201323.","journal-title":"J Thromb Haemost"},{"key":"1097_CR12","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.2337\/dc12-1048","volume":"36","author":"AE Lindgren","year":"2013","unstructured":"Lindgren AE, Kurki MI, Riihinen A, Koivisto T, Ronkainen A, Rinne J, et al. Type 2 diabetes and risk of rupture of saccular intracranial aneurysm in Eastern Finland. Diabetes Care. 2013;36:2020\u20136.","journal-title":"Diabetes Care"},{"key":"1097_CR13","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1093\/neuros\/nyx365","volume":"83","author":"IC Hostettler","year":"2018","unstructured":"Hostettler IC, Alg VS, Shahi N, Jichi F, Bonner S, Walsh D, et al. Characteristics of unruptured compared to ruptured intracranial aneurysms: a multicenter case\u2013control study. Neurosurgery. 2018;83:43\u201352.","journal-title":"Neurosurgery"},{"key":"1097_CR14","doi-asserted-by":"publisher","first-page":"e0246865","DOI":"10.1371\/journal.pone.0246865","volume":"16","author":"K Shimizu","year":"2021","unstructured":"Shimizu K, Imamura H, Tani S, Adachi H, Sakai C, Ishii A, et al. Candidate drugs for preventive treatment of unruptured intracranial aneurysms: a cross-sectional study. PLoS ONE. 2021;16:e0246865.","journal-title":"PLoS ONE"},{"key":"1097_CR15","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1160\/TH15-04-0316","volume":"114","author":"A Potteg\u00e5rd","year":"2015","unstructured":"Potteg\u00e5rd A, Garc\u00eda Rodr\u00edguez LA, Poulsen FR, Hallas J, Gaist D. Antithrombotic drugs and subarachnoid haemorrhage risk. A nationwide case-control study in Denmark. Thromb Haemost. 2015;114:1064\u201375.","journal-title":"Thromb Haemost"},{"key":"1097_CR16","doi-asserted-by":"publisher","first-page":"2887","DOI":"10.1161\/STROKEAHA.109.552760","volume":"40","author":"R Risselada","year":"2009","unstructured":"Risselada R, Straatman H, van Kooten F, Dippel DWJ, van der Lugt A, Niessen WJ, et al. Withdrawal of statins and risk of subarachnoid hemorrhage. Stroke. 2009;40:2887\u201392.","journal-title":"Stroke"},{"key":"1097_CR17","doi-asserted-by":"publisher","first-page":"e0247153","DOI":"10.1371\/journal.pone.0247153","volume":"16","author":"M Terce\u00f1o","year":"2021","unstructured":"Terce\u00f1o M, Remollo S, Silva Y, Bashir S, Werner M, Vera-Monge VA, et al. Effect of combined acetylsalicylic acid and statins treatment on intracranial aneurysm rupture. PLoS ONE. 2021;16:e0247153.","journal-title":"PLoS ONE"},{"key":"1097_CR18","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1161\/STROKEAHA.117.019249","volume":"49","author":"A Can","year":"2018","unstructured":"Can A, Castro VM, Yu S, Dligach D, Finan S, Gainer VS, et al. Antihyperglycemic agents are inversely associated with intracranial aneurysm rupture. Stroke. 2018;49:34\u20139.","journal-title":"Stroke"},{"key":"1097_CR19","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1111\/j.1538-7836.2010.03856.x","volume":"8","author":"M Schmidt","year":"2010","unstructured":"Schmidt M, Johansen MB, Lash TL, Christiansen CF, Christensen S, S\u00f8rensen HT. Antiplatelet drugs and risk of subarachnoid hemorrhage: a population-based case-control study. J Thromb Haemost. 2010;8:1468\u201374.","journal-title":"J Thromb Haemost"},{"key":"1097_CR20","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1161\/01.STR.0000074572.91827.F4","volume":"34","author":"JP Broderick","year":"2003","unstructured":"Broderick JP, Viscoli CM, Brott T, Kernan WN, Brass LM, Feldmann E, et al. Major risk factors for aneurysmal subarachnoid hemorrhage in the young are modifiable. Stroke. 2003;34:1375\u201381.","journal-title":"Stroke"},{"key":"1097_CR21","doi-asserted-by":"publisher","first-page":"e1175","DOI":"10.1212\/WNL.0000000000006200","volume":"91","author":"A Can","year":"2018","unstructured":"Can A, Rudy RF, Castro VM, Yu S, Dligach D, Finan S, et al. Association between aspirin dose and subarachnoid hemorrhage from saccular aneurysms. Neurology. 2018;91:e1175\u201381.","journal-title":"Neurology"},{"key":"1097_CR22","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1161\/STROKEAHA.107.497040","volume":"39","author":"N-K Choi","year":"2008","unstructured":"Choi N-K, Park B-J, Jeong S-W, Yu K-H, Yoon B-W. Nonaspirin nonsteroidal anti-inflammatory drugs and hemorrhagic stroke risk. Stroke. 2008;39:845\u20139.","journal-title":"Stroke"},{"key":"1097_CR23","doi-asserted-by":"publisher","first-page":"2422","DOI":"10.1161\/STROKEAHA.111.000811","volume":"44","author":"E Garbe","year":"2013","unstructured":"Garbe E, Kreisel SH, Behr S. Risk of subarachnoid hemorrhage and early case fatality associated with outpatient antithrombotic drug use. Stroke. 2013;44:2422\u20136.","journal-title":"Stroke"},{"key":"1097_CR24","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1212\/WNL.0b013e31829e6ffa","volume":"81","author":"LA Garcia-Rodriguez","year":"2013","unstructured":"Garcia-Rodriguez LA, Gaist D, Morton J, Cookson C, Gonzalez-Perez A. Antithrombotic drugs and risk of hemorrhagic stroke in the general population. Neurology. 2013;81:566\u201374.","journal-title":"Neurology"},{"key":"1097_CR25","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1161\/01.STR.30.9.1764","volume":"30","author":"H Iso","year":"1999","unstructured":"Iso H, Hennekens CH, Stampfer MJ, Rexrode KM, Colditz GA, Speizer FE, et al. Prospective study of aspirin use and risk of stroke in women. Stroke. 1999;30:1764\u201371.","journal-title":"Stroke"},{"key":"1097_CR26","doi-asserted-by":"publisher","first-page":"e132","DOI":"10.1016\/j.wneu.2019.12.045","volume":"136","author":"PL Nisson","year":"2019","unstructured":"Nisson PL, Meybodi AT, Secomb TW, Berger GK, Roe DJ, Lawton MT. Patients taking antithrombotic medications less frequently present with ruptured aneurysms. World Neurosurg. 2019;136:e132\u201340.","journal-title":"World Neurosurg"},{"key":"1097_CR27","doi-asserted-by":"publisher","first-page":"e19","DOI":"10.1212\/WNL.0000000000010997","volume":"96","author":"J-C Weng","year":"2021","unstructured":"Weng J-C, Wang J, Du X, Li H, Jiao Y-M, Fu W-L, et al. Safety of aspirin use in patients with stroke and small unruptured aneurysms. Neurology. 2021;96:e19-29.","journal-title":"Neurology"},{"key":"1097_CR28","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1161\/01.STR.0000053029.45352.A0","volume":"34","author":"S Bak","year":"2003","unstructured":"Bak S, Andersen M, Tsiropoulos I, Garc\u00eda Rodr\u00edguez LA, Hallas J, Christensen K, et al. Risk of stroke associated with nonsteroidal anti-inflammatory drugs: a nested case-control study. Stroke. 2003;34:379\u201386.","journal-title":"Stroke"},{"key":"1097_CR29","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1007\/s00415-005-0044-4","volume":"253","author":"YM Ruigrok","year":"2006","unstructured":"Ruigrok YM, Dekkers PJW, Bromberg JEC, Algra A, Rinkel GJE. Corticosteroid use and risk of aneurysmal subarachnoid haemorrhage. J Neurol. 2006;253:496\u20139.","journal-title":"J Neurol"},{"key":"1097_CR30","doi-asserted-by":"publisher","first-page":"2046","DOI":"10.1161\/STROKEAHA.118.022412","volume":"49","author":"A Can","year":"2018","unstructured":"Can A, Castro VM, Dligach D, Finan S, Yu S, Gainer V, et al. Elevated international normalized ratio is associated with ruptured aneurysms. Stroke. 2018;49:2046\u201352.","journal-title":"Stroke"},{"key":"1097_CR31","doi-asserted-by":"publisher","first-page":"3049","DOI":"10.1161\/STROKEAHA.107.491472","volume":"38","author":"J Kharofa","year":"2007","unstructured":"Kharofa J, Sekar P, Haverbusch M, Moomaw C, Flaherty M, Kissela B, et al. Selective serotonin reuptake inhibitors and risk of hemorrhagic stroke. Stroke. 2007;38:3049\u201351.","journal-title":"Stroke"},{"key":"1097_CR32","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1186\/s12974-020-01868-4","volume":"17","author":"S Li","year":"2020","unstructured":"Li S, Shi Y, Liu P, Song Y, Liu Y, Ying L, et al. Metformin inhibits intracranial aneurysm formation and progression by regulating vascular smooth muscle cell phenotype switching via the AMPK\/ACC pathway. J Neuroinflammation. 2020;17:191.","journal-title":"J Neuroinflammation"},{"key":"1097_CR33","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1093\/jnen\/nlz057","volume":"78","author":"K Shimizu","year":"2019","unstructured":"Shimizu K, Miyata H, Abekura Y, Oka M, Kushamae M, Kawamata T, et al. High-fat diet intake promotes the enlargement and degenerative changes in the media of intracranial aneurysms in rats. J Neuropathol Exp Neurol. 2019;78:798\u2013807.","journal-title":"J Neuropathol Exp Neurol"},{"key":"1097_CR34","doi-asserted-by":"publisher","first-page":"126","DOI":"10.2176\/nmc.st.2018-0326","volume":"59","author":"K Shimizu","year":"2019","unstructured":"Shimizu K, Kushamae M, Mizutani T, Aoki T. Intracranial aneurysm as a macrophage-mediated inflammatory disease. Neurol Med Chir (Tokyo). 2019;59:126\u201332.","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"1097_CR35","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1161\/CIRCRESAHA.116.308537","volume":"120","author":"A Oesterle","year":"2017","unstructured":"Oesterle A, Laufs U, Liao JK. Pleiotropic effects of statins on the cardiovascular system. Circ Res. 2017;120:229\u201343.","journal-title":"Circ Res"},{"key":"1097_CR36","doi-asserted-by":"publisher","first-page":"196","DOI":"10.2174\/1871530315666150316124019","volume":"15","author":"Y Saisho","year":"2015","unstructured":"Saisho Y. Metformin and inflammation: its potential beyond glucose-lowering effect. Endocr Metab Immune Disord Drug Targets. 2015;15:196\u2013205.","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"1097_CR37","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1111\/j.1476-5381.2011.01358.x","volume":"163","author":"T Aoki","year":"2011","unstructured":"Aoki T, Nishimura M, Matsuoka T, Yamamoto K, Furuyashiki T, Kataoka H, et al. PGE(2) -EP(2) signalling in endothelium is activated by haemodynamic stress and induces cerebral aneurysm through an amplifying loop via NF-\u03baB. Br J Pharmacol. 2011;163:1237\u201349.","journal-title":"Br J Pharmacol"},{"key":"1097_CR38","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1212\/WNL.0000000000006394","volume":"91","author":"M Edjlali","year":"2018","unstructured":"Edjlali M, Boulouis G, Derraz I, Ben Hassen W, Rodriguez-R\u00e9gent C, Trystram D, et al. Intracranial aneurysm wall enhancement decreases under anti-inflammatory treatment. Neurology. 2018;91:804\u20135.","journal-title":"Neurology"},{"key":"1097_CR39","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1161\/STROKEAHA.114.005461","volume":"45","author":"N Etminan","year":"2014","unstructured":"Etminan N, Dreier R, Buchholz BA, Beseoglu K, Bruckner P, Matzenauer C, et al. Age of collagen in intracranial saccular aneurysms. Stroke. 2014;45:1757\u201363.","journal-title":"Stroke"},{"key":"1097_CR40","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1161\/STROKEAHA.120.029335","volume":"51","author":"KAM Hackenberg","year":"2020","unstructured":"Hackenberg KAM, Rajabzadeh-Oghaz H, Dreier R, Buchholz BA, Navid A, Rocke DM, et al. Collagen turnover in relation to risk factors and hemodynamics in human intracranial aneurysms. Stroke. 2020;51:1624\u20138.","journal-title":"Stroke"},{"key":"1097_CR41","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1093\/jnen\/nlab037","volume":"80","author":"K Shimizu","year":"2021","unstructured":"Shimizu K, Imai H, Kawashima A, Okada A, Ono I, Miyamoto S, et al. Induction of CCN1 in Growing saccular aneurysms: a potential marker predicting unstable lesions. J Neuropathol Exp Neurol. 2021;80:695\u2013704.","journal-title":"J Neuropathol Exp Neurol"},{"key":"1097_CR42","doi-asserted-by":"publisher","first-page":"2723","DOI":"10.1016\/0006-2952(88)90034-2","volume":"37","author":"R Hein","year":"1988","unstructured":"Hein R, Mauch C, Hatamochi A, Krieg T. Influence of corticosteroids on chemotactic response and collagen metabolism of human skin fibroblasts. Biochem Pharmacol. 1988;37:2723\u20139.","journal-title":"Biochem Pharmacol"}],"container-title":["Translational Stroke Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12975-022-01097-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12975-022-01097-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12975-022-01097-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,11]],"date-time":"2023-11-11T20:08:12Z","timestamp":1699733292000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12975-022-01097-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,15]]},"references-count":42,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["1097"],"URL":"https:\/\/doi.org\/10.1007\/s12975-022-01097-2","relation":{},"ISSN":["1868-4483","1868-601X"],"issn-type":[{"value":"1868-4483","type":"print"},{"value":"1868-601X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,15]]},"assertion":[{"value":"7 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}